Darla Bagwell
Adult Health · Port Saint Lucie, FLNPI 1801884028
Payments from drug & device makers
Across 350 payments — averaging $19.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$3K
- Gilead$2K
- Merck$761
- Johnson & Johnson$456
- AbbVie$363
- Theratechnologies Inc.$185
- plus $216 from 6 others
What the payments were for
- Food & beverage$6,60999%
- Education$491%
- Gifts$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 132 | $2,594 |
| Gilead | 109 | $2,101 |
| Merck | 34 | $761 |
| Johnson & Johnson | 36 | $456 |
| AbbVie | 18 | $363 |
| Theratechnologies Inc. | 10 | $185 |
| Melinta Therapeutics, LLC | 4 | $79 |
| EMD Serono, Inc. | 2 | $34 |
| Ascend Therapeutics US, LLC | 2 | $32 |
| Janssen Products, LP | 1 | $31 |
| Shionogi Inc | 1 | $27 |
| Astellas Pharma US Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,676 in reported general payments places this provider in the 90th percentile of 2,237 adult health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 757 | $3,112,952 |
| DovatoDolutegravir Sodium/Lamivudine | 335 | $979,485 |
| TivicayDolutegravir Sodium | 320 | $824,896 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 134 | $695,496 |
| DescovyEmtricitabine/Tenofov Alafenam | 143 | $309,676 |
| RukobiaFostemsavir Tromethamine | 32 | $280,579 |
| PrezcobixDarunavir/Cobicistat | 92 | $235,248 |
| PifeltroDoravirine | 131 | $229,289 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 56 | $189,709 |
| JulucaDolutegravir/Rilpivirine | 50 | $178,080 |
| CabenuvaCabotegravir/Rilpivirine | 22 | $142,418 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 25 | $95,998 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 24 | $85,494 |
| IsentressRaltegravir Potassium | 12 | $27,218 |
| EvotazAtazanavir Sulfate/Cobicistat | 12 | $17,749 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy, Genvoya | $2,101 | $3,518,626925 claims |
| Viiv Healthcare CompanyDovato, Tivicay, Rukobia, Juluca, Cabenuva | $2,594 | $2,490,951783 claims |
| Janssen Products, LPSymtuza | $31 | $695,496134 claims |
| MerckPifeltro, Isentress, Januvia | $761 | $262,649154 claims |
| Johnson & JohnsonPrezcobix | $456 | $235,24892 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,237 adult health providers in Florida.
Other adult health in Port Saint Lucie
- Patricia PagnottaMaitland$441K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Alejandro Dela CruzOrlando$44K
- Cynthia OteroMaitland$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.